Global Leader in Coagulation Testing

Overview

BioCascade Incorporated was founded in 2000 and opened its laboratory in Arlington, Wisconsin in early 2001. The company automated and validated the USP anti-factor Xa heparin test in mid-2002 and BioCascade began testing heparin and related products for pharmaceutical and medical device companies.

Since its founding, BioCascade has focused its development efforts towards automated versions of Anti-Xa and Anti-IIa heparin assays. Company founder and President, Patrick N. Shaklee, Ph.D. served for many years on WHO and USP Expert panels to further the implementation and standardization of chromogenic heparin testing.

In 2007, BioCascade developed the Kinetichrome™ line of Anti-Xa and Anti-IIa Heparin test kits, the first chromogenic kits specifically developed for use in plasma-free industrial and pharmacopeial applications. In 2009, a sister company, Provision Kinetics (www.provisionkinetics.com) was established to produce and market Kinetichrome™ Anti-Xa and Anti-IIa heparin kits, as well as other related products.

BioCascade, Inc.
107 Skyline Drive
P.O. Box 98
Arlington, WI 53911-0098

Phone: 608.635.9899
FAX: 608.635.8985